As reported in Law360, end-payors of the prescription drug Restasis won class certification in pending antitrust litigation in Brooklyn federal court. The court also appointed Girard Sharp to serve as co-lead class counsel.
Follow us on Instagram and Twitter @GirardSharp for case-related updates.
